The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Mechlorethamine results in increased expression of and results in decreased localization of BAX protein; Mechlorethamine results in increased expression of and results in increased activity of BAX protein
Mechlorethamine results in increased activity of CASP3 protein ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP3 protein]
Mechlorethamine results in increased activity of CASP9 protein ebselen inhibits the reaction [Mechlorethamine results in increased activity of CASP9 protein]; Mechlorethamine results in increased cleavage of and results in increased activity of CASP9 protein
Mechlorethamine results in decreased activity of [CCNA2 protein binds to CDK2 protein]; Mechlorethamine results in increased expression of and results in increased activity of [CDK2 protein binds to CCNA2 protein]; Pentoxifylline inhibits the reaction [Mechlorethamine results in increased activity of [CCNA2 protein binds to CDK2 protein]] Mechlorethamine results in increased stability of CCNA2 protein
Mechlorethamine results in decreased activity of CCNB1 protein Mechlorethamine results in decreased activity of [CCNB1 protein binds to CDK1 protein]; Pentoxifylline inhibits the reaction [Mechlorethamine results in decreased activity of [CCNB1 protein binds to CDK1 protein]]
Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of CCR2 mRNA] Mechlorethamine results in increased expression of CCR2 mRNA; Mechlorethamine results in increased expression of CCR2 protein
Mechlorethamine results in increased expression of CD163 protein NR1H4 protein affects the reaction [Mechlorethamine results in increased expression of CD163 protein]
Mechlorethamine results in decreased activity of [CCNB1 protein binds to CDK1 protein]; Pentoxifylline inhibits the reaction [Mechlorethamine results in decreased activity of [CCNB1 protein binds to CDK1 protein]] Mechlorethamine results in increased stability of CDK1 protein modified form Mechlorethamine results in decreased activity of CDK1 protein
Mechlorethamine results in increased activity of CDK2 protein Mechlorethamine results in decreased activity of [CCNA2 protein binds to CDK2 protein]; Mechlorethamine results in increased expression of and results in increased activity of [CDK2 protein binds to CCNA2 protein]; Pentoxifylline inhibits the reaction [Mechlorethamine results in increased activity of [CCNA2 protein binds to CDK2 protein]]
Mechlorethamine results in increased expression of CX3CR1 mRNA; Mechlorethamine results in increased expression of CX3CR1 protein Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of CX3CR1 mRNA]
[Mechlorethamine co-treated with Dimethyl Sulfoxide] results in increased phosphorylation of EIF4EBP1 protein; Mechlorethamine inhibits the reaction [Dimethyl Sulfoxide results in increased phosphorylation of EIF4EBP1 protein]
Mechlorethamine results in increased expression of and affects the localization of FOS protein; Mechlorethamine results in increased phosphorylation of and results in increased expression of FOS protein FOS protein affects the reaction [Mechlorethamine results in increased secretion of CXCL8 protein]
FOSB protein affects the reaction [Mechlorethamine results in increased secretion of CXCL8 protein]; FOSL1 protein affects the reaction [Mechlorethamine results in increased expression of and affects the localization of FOSB protein]; Mechlorethamine results in increased expression of and affects the localization of FOSB protein; U 0126 inhibits the reaction [Mechlorethamine results in increased expression of FOSB protein]
Mechlorethamine results in increased expression of FOSL1 protein FOSL1 protein affects the reaction [Mechlorethamine results in increased expression of and affects the localization of FOSB protein]; FOSL1 protein affects the reaction [Mechlorethamine results in increased expression of CXCL8 mRNA]; FOSL1 protein affects the reaction [Mechlorethamine results in increased secretion of CXCL8 protein]; Mechlorethamine promotes the reaction [FOSL1 protein binds to JUN protein]; Mechlorethamine promotes the reaction [FOSL1 protein binds to JUNB protein]; Mechlorethamine promotes the reaction [FOSL1 protein binds to JUND protein]; Mechlorethamine results in increased expression of and affects the localization of FOSL1 protein; U 0126 inhibits the reaction [Mechlorethamine results in increased expression of FOSL1 protein]
Mechlorethamine results in increased expression of FOSL2 protein FOSL2 protein affects the reaction [Mechlorethamine results in increased secretion of CXCL8 protein]
Mechlorethamine results in increased expression of HMOX1; Mechlorethamine results in increased expression of HMOX1 protein NR1H4 protein affects the reaction [Mechlorethamine results in increased expression of HMOX1]; SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of HMOX1 protein] Acetylcysteine inhibits the reaction [Mechlorethamine results in increased expression of HMOX1 protein]; Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of HMOX1 protein]
Mechlorethamine results in increased expression of IL10 mRNA Valproic Acid promotes the reaction [Mechlorethamine results in increased expression of IL10 mRNA]
Mechlorethamine results in increased expression of IL12B mRNA Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of IL12B mRNA]
KIT gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of IL6 mRNA] Acetylcysteine inhibits the reaction [Mechlorethamine results in increased expression of IL6 mRNA]
Mechlorethamine results in increased phosphorylation of JUN protein Mechlorethamine results in increased expression of and affects the localization of JUN protein Mechlorethamine results in increased expression of JUN protein Mechlorethamine promotes the reaction [FOSL1 protein binds to JUN protein]; U 0126 inhibits the reaction [Mechlorethamine results in increased expression of JUN protein]
Mechlorethamine promotes the reaction [FOSL1 protein binds to JUNB protein]; U 0126 inhibits the reaction [Mechlorethamine results in increased expression of JUNB protein] Mechlorethamine results in increased expression of and affects the localization of JUNB protein
Mechlorethamine promotes the reaction [FOSL1 protein binds to JUND protein]; U 0126 inhibits the reaction [Mechlorethamine results in increased expression of JUND protein] Mechlorethamine results in increased expression of and affects the localization of JUND protein
KIT gene mutant form affects the susceptibility to Mechlorethamine KIT gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of IL1B mRNA]; KIT gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of IL33 mRNA]; KIT gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of IL6 mRNA]; KIT gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of PTGS2 mRNA]; KIT gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of TNF mRNA]
Mechlorethamine results in increased phosphorylation of MAPK1 protein Mechlorethamine results in increased phosphorylation of and affects the localization of MAPK1 protein
Mechlorethamine results in increased phosphorylation of MAPK3 protein Mechlorethamine results in increased phosphorylation of and affects the localization of MAPK3 protein
Mechlorethamine results in increased expression of MMP9; Mechlorethamine results in increased expression of MMP9 protein Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of MMP9 mRNA] Mechlorethamine results in increased expression of MMP9 mRNA; Mechlorethamine results in increased expression of MMP9 protein MPO gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of MMP9]; SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of MMP9 protein]
MPO gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of MMP9]; MPO gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of NOS2]; MPO gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of PTGS2] MPO protein results in increased susceptibility to Mechlorethamine
Mechlorethamine results in increased expression of MRC1 protein SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of MRC1 protein]
Mechlorethamine results in increased expression of NOS2; Mechlorethamine results in increased expression of NOS2 protein Acetylcysteine inhibits the reaction [Mechlorethamine results in increased expression of NOS2 mRNA]; Acetylcysteine inhibits the reaction [Mechlorethamine results in increased expression of NOS2 protein]; Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of NOS2 mRNA] Mechlorethamine results in increased expression of NOS2 mRNA; Mechlorethamine results in increased expression of NOS2 protein MPO gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of NOS2]; SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of NOS2 protein]
[NR1H4 protein affects the susceptibility to Mechlorethamine] which affects the expression of MIR146 mRNA; [NR1H4 protein affects the susceptibility to Mechlorethamine] which affects the expression of MIR223 mRNA; NR1H4 protein affects the reaction [Mechlorethamine results in increased expression of ARL11 protein]; NR1H4 protein affects the reaction [Mechlorethamine results in increased expression of CD163 protein]; NR1H4 protein affects the reaction [Mechlorethamine results in increased expression of HMOX1]; NR1H4 protein affects the reaction [Mechlorethamine results in increased expression of PTGS2 protein]; NR1H4 protein affects the reaction [Mechlorethamine results in increased expression of STAT6 protein]
Mechlorethamine results in increased expression of PCNA; Mechlorethamine results in increased expression of PCNA protein Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of PCNA protein]
Mechlorethamine results in increased expression of PTGS2; Mechlorethamine results in increased expression of PTGS2 mRNA; Mechlorethamine results in increased expression of PTGS2 protein Acetylcysteine inhibits the reaction [Mechlorethamine results in increased expression of PTGS2 mRNA]; Acetylcysteine inhibits the reaction [Mechlorethamine results in increased expression of PTGS2 protein]; Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of PTGS2 mRNA] KIT gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of PTGS2 mRNA]; MPO gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of PTGS2]; NR1H4 protein affects the reaction [Mechlorethamine results in increased expression of PTGS2 protein]
Mechlorethamine affects the reaction [Dimethyl Sulfoxide affects the phosphorylation of RPS6 protein] [Dimethyl Sulfoxide co-treated with Mechlorethamine] results in increased phosphorylation of RPS6 protein; Mechlorethamine inhibits the reaction [Dimethyl Sulfoxide results in increased phosphorylation of RPS6 protein]
Mechlorethamine results in increased expression of SFTPD protein SFTPD gene mutant form results in increased susceptibility to Mechlorethamine SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of CHIL3 protein]; SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of HMOX1 protein]; SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of MMP9 protein]; SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of MRC1 protein]; SFTPD gene mutant form promotes the reaction [Mechlorethamine results in increased expression of NOS2 protein]
Mechlorethamine results in increased expression of SOD2; Mechlorethamine results in increased expression of SOD2 protein Valproic Acid inhibits the reaction [Mechlorethamine results in increased expression of SOD2 protein]
Mechlorethamine results in increased expression of TNF mRNA; Mechlorethamine results in increased expression of TNF protein Acetylcysteine inhibits the reaction [Mechlorethamine results in increased expression of TNF protein] KIT gene mutant form inhibits the reaction [Mechlorethamine results in increased expression of TNF mRNA]
Mechlorethamine results in increased phosphorylation of and results in increased expression of TRP53 protein Mechlorethamine binds to TP53 protein Mechlorethamine results in increased expression of and affects the localization of TP53 protein; Mechlorethamine results in increased phosphorylation of and results in increased acetylation of TP53 protein Mechlorethamine results in decreased activity of TP53 protein Mechlorethamine results in increased stability of TP53 protein Mechlorethamine results in increased alkylation of TP53 protein TRP53 affects the susceptibility to Mechlorethamine; TRP53 protein affects the susceptibility to Mechlorethamine Mechlorethamine results in increased expression of TP53 protein
[NADP co-treated with Mechlorethamine] results in decreased activity of TXNRD1 protein [NADP co-treated with Mechlorethamine] promotes the reaction [TXNRD1 protein binds to TXNRD1 protein]; [NADP co-treated with Mechlorethamine] results in decreased activity of and results in increased alkylation of TXNRD1 protein